Perfil
Kole T.
Roybal is the founder of Arsenal Biosciences, Inc., founded in 2019.
Dr. Roybal is the founder of Dispatch Biotherapeutics, Inc., founded in 2022.
Dr. Roybal is also the founder of Moonlight Bio, Inc...
Dr. Roybal is currently an Advisor at Venrock Associates since 2020.
Cargos activos de Kole Roybal
| Empresas | Cargo | Inicio |
|---|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Consultor / Asesor | 01/09/2020 |
Dispatch Biotherapeutics, Inc.
Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Fundador | 01/01/2022 |
Antiguos cargos conocidos de Kole Roybal.
| Empresas | Cargo | Fin |
|---|---|---|
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Health Technology |
Dispatch Biotherapeutics, Inc.
Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Health Technology |
- Bolsa de valores
- Insiders
- Kole Roybal
















